Patient characteristics and associations with bleeding score
| . | . | Univariate association with bleeding score . | Association with bleeding score adjusted for platelet count . | ||
|---|---|---|---|---|---|
| Parameter . | N, Mean or Median . | P . | OR per unit or 1 SD (95% CI) . | P . | OR per unit or 1 SD (95% CI) . |
| Gender | Female, n = 26 | .0180 | Female vs male; 3.35 (1.23-9.13) | .1137 | — |
| Male, n = 31 | |||||
| Age (y) | 9.9 ± 5.4 | .5260 | — | — | — |
| Ethnicity | Not Hispanic, n = 39 | .4107 | — | — | — |
| Hispanic, n = 7 | |||||
| Unknown, n = 11 | |||||
| Platelet count (× 109/L) | 59 (IQR 14-125)* | .0080 | 0.925† (0.874-0.980) | — | — |
| ITP duration | New (<3 mo), n = 20 | .0024 | New vs chronic; 8.26 (2.51-27.2) | .0002 | New vs chronic; 16.2 (4.29-61.0) |
| Persistent (3-12 mo), n = 9 | |||||
| Chronic (>12 mo), n = 28 | |||||
| Diagnosis | Primary (n = 47), Evans (n = 7), Non-Evans Secondary (n = 3) | .0222 | Primary vs Evans; 18.9 (2.03-175) | — | — |
| Medical treatment | Any (n = 25) vs | .5933 | — | — | — |
| None (n = 32) | |||||
| Steroids (n = 15) vs | .7923 | — | — | — | |
| Not steroids, n = 42 | |||||
| Antecedent viral illness | No, n = 29 vs | .0919 | — | — | — |
| Yes, n = 18 | |||||
| Unknown, n = 10 | |||||
| . | . | Univariate association with bleeding score . | Association with bleeding score adjusted for platelet count . | ||
|---|---|---|---|---|---|
| Parameter . | N, Mean or Median . | P . | OR per unit or 1 SD (95% CI) . | P . | OR per unit or 1 SD (95% CI) . |
| Gender | Female, n = 26 | .0180 | Female vs male; 3.35 (1.23-9.13) | .1137 | — |
| Male, n = 31 | |||||
| Age (y) | 9.9 ± 5.4 | .5260 | — | — | — |
| Ethnicity | Not Hispanic, n = 39 | .4107 | — | — | — |
| Hispanic, n = 7 | |||||
| Unknown, n = 11 | |||||
| Platelet count (× 109/L) | 59 (IQR 14-125)* | .0080 | 0.925† (0.874-0.980) | — | — |
| ITP duration | New (<3 mo), n = 20 | .0024 | New vs chronic; 8.26 (2.51-27.2) | .0002 | New vs chronic; 16.2 (4.29-61.0) |
| Persistent (3-12 mo), n = 9 | |||||
| Chronic (>12 mo), n = 28 | |||||
| Diagnosis | Primary (n = 47), Evans (n = 7), Non-Evans Secondary (n = 3) | .0222 | Primary vs Evans; 18.9 (2.03-175) | — | — |
| Medical treatment | Any (n = 25) vs | .5933 | — | — | — |
| None (n = 32) | |||||
| Steroids (n = 15) vs | .7923 | — | — | — | |
| Not steroids, n = 42 | |||||
| Antecedent viral illness | No, n = 29 vs | .0919 | — | — | — |
| Yes, n = 18 | |||||
| Unknown, n = 10 | |||||